Literature DB >> 8557041

Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro.

J Sedman1, A Stenlund.   

Abstract

The E1 polypeptide from bovine papillomavirus binds to the origin of replication (ori) and possesses the activities attributed to initiator proteins. E1 is also the only viral protein required for replication in a cell-free replication system. Replication in vivo, however, absolutely requires in addition the viral transcription factor E2. We demonstrate that the basis for this distinction between in vitro and in vivo requirements is the limited sequence specificity of the E1 protein. E1 and E2, which bind the ori individually with low sequence specificity, together bind with greatly increased sequence specificity. This combinatorial effect provides a function for the involvement of transcriptional activation domains in replication and suggests common mechanisms of action for transcription factors in both transcription and replication. It also provides a possible explanation for the differential specificity that is observed for auxiliary transcription factors in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557041      PMCID: PMC394746          DOI: 10.1002/j.1460-2075.1995.tb00312.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  44 in total

1.  Protein-protein interactions between adenovirus DNA polymerase and nuclear factor I mediate formation of the DNA replication preinitiation complex.

Authors:  M Chen; N Mermod; M S Horwitz
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

2.  Activation of BPV-1 replication in vitro by the transcription factor E2.

Authors:  L Yang; R Li; I J Mohr; R Clark; M R Botchan
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

3.  Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome.

Authors:  R Li; J Knight; G Bream; A Stenlund; M Botchan
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

4.  Transcriptional activator nuclear factor I stimulates the replication of SV40 minichromosomes in vivo and in vitro.

Authors:  L Cheng; T J Kelly
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

5.  Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro.

Authors:  K A Jones; K R Yamamoto; R Tjian
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

6.  Bacteriophage lambda repressor and cro protein: interactions with operator DNA.

Authors:  A D Johnson; C O Pabo; R T Sauer
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

Review 7.  lambda Repressor and cro--components of an efficient molecular switch.

Authors:  A D Johnson; A R Poteete; G Lauer; R T Sauer; G K Ackers; M Ptashne
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

8.  A bovine papillomavirus E1-related protein binds specifically to bovine papillomavirus DNA.

Authors:  V G Wilson; J Ludes-Meyers
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  Mechanism of action of the cro protein of bacteriophage lambda.

Authors:  A Johnson; B J Meyer; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

10.  Replication of bovine papillomavirus type 1 origin-containing DNA in crude extracts and with purified proteins.

Authors:  F Müller; Y S Seo; J Hurwitz
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

View more
  81 in total

1.  Separate domains in E1 and E2 proteins serve architectural and productive roles for cooperative DNA binding.

Authors:  E Gillitzer; G Chen; A Stenlund
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

2.  Two patches of amino acids on the E2 DNA binding domain define the surface for interaction with E1.

Authors:  G Chen; A Stenlund
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  The E1 initiator recognizes multiple overlapping sites in the papillomavirus origin of DNA replication.

Authors:  G Chen; A Stenlund
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Crystal structures of two intermediates in the assembly of the papillomavirus replication initiation complex.

Authors:  Eric J Enemark; Arne Stenlund; Leemor Joshua-Tor
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

5.  Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins.

Authors:  T Yasugi; M Vidal; H Sakai; P M Howley; J D Benson
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  E1 initiator DNA binding specificity is unmasked by selective inhibition of non-specific DNA binding.

Authors:  Arne Stenlund
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

7.  The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2.

Authors:  Eric A Abbate; James M Berger; Michael R Botchan
Journal:  Genes Dev       Date:  2004-08-02       Impact factor: 11.361

Review 8.  Two heads are better than one: regulation of DNA replication by hexameric helicases.

Authors:  Robert A Sclafani; Ryan J Fletcher; Xiaojiang S Chen
Journal:  Genes Dev       Date:  2004-09-01       Impact factor: 11.361

9.  Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.

Authors:  Jasmin Fertey; Ingo Ammermann; Michael Winkler; Reinhard Stöger; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

10.  Identification of a short, hydrophilic amino acid sequence critical for origin recognition by the bovine papillomavirus E1 protein.

Authors:  A Gonzalez; C Bazaldua-Hernandez; M West; K Woytek; V G Wilson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.